21st Century Oncology Inc:企業の戦略的SWOT分析

◆英語タイトル:21st Century Oncology Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15786
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

21st Century Oncology Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

21st Century Oncology Inc (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services. It provides radiation therapy and integrated cancer care services to patients. The company has affiliations with physicians specializing in the areas of medical oncology, urology, gynecological, breast and surgical oncology, general surgery, radiation oncology, and primary care. It also offers specialized delivery systems for internal beam radiation therapy. The company operates through international treatment centers operations in the US and in certain Latin American markets. 21st Century Oncology is headquartered in Fort Myers, Florida, the US.

21st Century Oncology Inc Key Recent Developments

Mar 14,2019 21st Century Oncology bolsters its best-in-class Oncology dream team by adding five nationally renowned physicians
Jan 07,2019 21st Century Oncology hires Powell as chief operating officer
Apr 18,2018 21st Century Oncology Names Kimberly Commins-Tzoumakas As Chief Executive Officer

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
21st Century Oncology Inc – Key Facts
21st Century Oncology Inc – Key Employees
21st Century Oncology Inc – Key Employee Biographies
21st Century Oncology Inc – Major Products and Services
21st Century Oncology Inc – History
21st Century Oncology Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
21st Century Oncology Inc – Business Description
21st Century Oncology Inc – SWOT Analysis
SWOT Analysis – Overview
21st Century Oncology Inc – Strengths
21st Century Oncology Inc – Weaknesses
21st Century Oncology Inc – Opportunities
21st Century Oncology Inc – Threats
21st Century Oncology Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
21st Century Oncology Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 14, 2019: 21st Century Oncology bolsters its best-in-class Oncology dream team by adding five nationally renowned physicians
Jan 07, 2019: 21st Century Oncology hires Powell as chief operating officer
Apr 18, 2018: 21st Century Oncology Names Kimberly Commins-Tzoumakas As Chief Executive Officer
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
21st Century Oncology Inc, Key Facts
21st Century Oncology Inc, Key Employees
21st Century Oncology Inc, Key Employee Biographies
21st Century Oncology Inc, Major Products and Services
21st Century Oncology Inc, History
21st Century Oncology Inc, Other Locations
21st Century Oncology Inc, Subsidiaries
21st Century Oncology Inc, Key Competitors
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
21st Century Oncology Inc, Recent Deals Summary

List of Figures
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[21st Century Oncology Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oil Basins Limited (OBL):企業財務及び戦略的SWOT分析
    Summary Oil Basins Limited (Oil Basins) is an oil and gas company that develops, explores and produces crude oil and natural gas. The company explores oil and gas properties in offshore Gippsland Basin waters of south-eastern Australia, onshore Canning Basin of Western Australia, and offshore Carnar …
  • Jerusalem Pharmaceutical Co. Ltd (JPH):企業の財務及び戦略的SWOT分析
    Summary Jerusalem Pharmaceutical Co. Ltd (Jerusalem Pharma) is a pharmaceutical company that develops, manufactures and markets generic pharmaceuticals. Its product portfolio spans cosmetics and drugs for. personal and household care. The company produces more than 200 medicinal preparation various …
  • Neuron Biopharma SA (NEU):企業財務及び戦略的SWOT分析
    Summary Neuron Biopharma SA (NBP) is a pharmaceutical company that discovers and develops biosolutions. The company provides pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treat …
  • Maxim Power Corp. (MXG):企業の財務・戦略的SWOT分析
    Maxim Power Corp. (MXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • Success Electronics & Transformer Manufacturer Sdn. Bhd. (SUCCESS):企業財務及び戦略的SWOT分析
    Summary Success Electronics & Transformer Manufacturer Sdn. Bhd. (Success Electronics) is an electric equipment company that manufactures and markets low voltage transformers and industrial lighting products. The company’s products include industrial lighting, commercial lighting, outdoor commercial …
  • Solazyme, Inc.:企業のM&A・提携・投資分析
    Solazyme, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Solazyme, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Assima PLC (ALSIM):企業の財務及び戦略的SWOT分析
    Summary Assima PLC (Assima) is an information technology company that develops and distributes cloning solutions. The company offers solutions used in training client that enables the creation of training content. Its products include training suite, multilingual suite, change management suite, STT …
  • Innovent Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Fujikura Kasei Co., Ltd. (4620):企業概要、財務及び戦略的SWOT分析
    Summary Fujikura Kasei Co., Ltd. (Fujikura) is a chemical product company. The company develops, manufactures, and sells specialty chemicals. It offers coatings for plastics, architectural coatings, electronics materials, and polymers and resins. Fujikura’s coatings for plastics include automotive i …
  • CareGroup, Inc.:企業の戦略的SWOT分析
    CareGroup, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Didion Milling Inc.:戦略・SWOT・企業財務分析
    Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report Summary Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Metabolic Solutions Development Co.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Metabolic Solutions Development …
  • CITIC Securities Company Limited (600030):企業財務及び戦略的SWOT分析
    Summary CITIC Securities Company Limited (CITIC) is a securities brokerage firm that offers financial services. The firm’s services include investment banking, corporate development financing, brokerage, trading and derivatives. It offers asset management, goldstone investment, fixed income sales an …
  • Stork Technical Services HOLDCO B.V.:企業のM&A・提携動向(石油・ガス分野)
    Summary Stork Technical Services HOLDCO B.V. (Stork) is a provider of asset integrity management services to diverse sectors. The company provides a range of solutions and specialist services that span all areas of asset management and maintenance. Its service portfolio includes maintenance and proj …
  • DePuy Synthes Companies:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DePuy Synthes Companies Mergers …
  • SouthGobi Resources Ltd.:企業の戦略・SWOT・財務分析
    SummarySouthGobi Resources Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Sumitomo Densetsu Co., Ltd. (1949):企業概要、財務及び戦略的SWOT分析
    Summary Sumitomo Densetsu Co., Ltd. (Sumitomo) is a construction company. The company develops electric facilities and others. Its services include electrical and air conditioning, renewal and maintenance, engineering, and information and communication. Sumitomo provides engineering service such as …
  • Concert Pharmaceuticals, Inc. (CNCE)(製薬・医療分野):企業M&A動向
    Summary Concert Pharmaceuticals, Inc. (Concert Pharmaceuticals) is a pharmaceutical company. The company creates novel medicines by applying our DCE Platform (Deuterated Chemical Entity Platform). Its products pipeline include CTP-354: used in the treatment of multiple sclerosis and spinal cord inju …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆